FARN

SIGnet after-meeting on Faron Pharmaceuticals
3 November 2020

SIGnet after-meeting on Faron Pharmaceuticals Date: 3rd November 2020 Time: 6:10pm - 7:10pm SIGnet is a UK-wide network of investor groups that meet regularly  (in-person or online) to discuss investing topics and companies of interest to members. SIGnet after-meetings take place after ShareSoc webinars and use Zoom technology to enable members to discuss the presenting company. The meetings are chaired to provide structure and enable all members to take part. Online resources such as Stockopedia are used to support the discussion. Attendance is free for existing SIGnet subscribers. Others are welcome to attend this after-meeting and other SIGnet meetings ...

ShareSoc Webinar with Faron Pharmaceuticals (FARN)
3 November 2020

Company: Faron Pharmaceuticals (FARN) Date: 3rd November 2020 Time: 5pm start - 6pm finish Presenter: Markku Jalkanen, CEO Format: Webinar Company Information: Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, ...